Kartogenin TCI K0078

TCI K0078 Kartogenin is a small-molecule compound widely used as a research reagent in the field of stem cell biology, particularly in studies of chondrogenic differentiation. The compound is well established in the scientific literature for its ability to drive mesenchymal stem cells toward differentiation into chondrocytes, the cells that make up cartilage tissue. Its reported mechanism involves binding to filamin A, thereby releasing CBFβ, which subsequently acts together with RUNX1 inside the cell nucleus. In the laboratory its role is that of a controlled differentiation inducer in cell culture experiments and tissue engineering work.

The property that makes kartogenin a preferred choice is its status as a stable synthetic small molecule, which makes it far more practical to work with than protein growth factors that degrade readily, are sensitive to temperature, and are difficult to maintain at a consistent concentration in medium over long periods. Kartogenin can be dissolved in the organic solvents commonly used in cell culture, added directly to the medium, and its dose is easily adjusted for concentration-response experiments. Because it acts on a relatively specific transcriptional pathway, the compound also produces a more consistent and interpretable phenotype in differentiation studies.

In Indonesian laboratories, TCI K0078 is typically used in university research groups, biomedical institutes, and tissue engineering programmes that work with mesenchymal stem cell cultures. It fits routine workflows where differentiation is induced in monolayer or pellet culture and the resulting chondrogenic markers are then assessed. Its stability as a synthetic reagent is especially valuable in local settings, where cold-chain handling of protein growth factors can be difficult to maintain reliably across long distribution routes.

• Chondrogenic differentiation studies: kartogenin is used to induce mesenchymal stem cells toward a chondrocyte phenotype, giving researchers a reproducible chemical trigger in place of protein growth factors.
• Cartilage tissue engineering research: the compound supports experiments that build cartilage-like constructs, since it can be added directly to culture medium and maintained at a stable concentration over extended culture periods.
• Concentration-response experiments: because kartogenin is a defined small molecule that dissolves in common culture solvents, its dose can be adjusted precisely across a series of experimental conditions.
• Stem cell signalling pathway investigation: researchers use kartogenin to probe the filamin A, CBFβ and RUNX1 axis, since its reported mechanism acts on a relatively specific transcriptional pathway.
• Cell culture reagent screening and comparison: kartogenin serves as a well-documented reference compound in the literature, allowing laboratories to benchmark new differentiation protocols against a widely recognised inducer.

Store TCI K0078 Kartogenin in its original tightly closed container, following the storage conditions stated on the manufacturer's label and accompanying documentation. Keep the container protected from moisture and from prolonged exposure to light, and allow refrigerated or frozen material to reach room temperature before opening to reduce condensation inside the vial. Prepare stock solutions in suitable organic solvents in a clean environment, and aliquot them into inert, well-sealed vials to limit repeated freeze-thaw cycles. Handle the compound in a laboratory setting using standard personal protective equipment, including gloves, laboratory coat and eye protection, and work in a fume hood or biological safety cabinet as appropriate for the procedure. Consult the safety data sheet before use and dispose of residues in accordance with institutional chemical waste procedures.

—